REPORT ID 15846

United States Specialty Injectable Generics Market Report 2019

Publish Date
2019
Pages
108
Format
Electronic (PDF)

In this report, the United States Specialty Injectable Generics market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Specialty Injectable Generics in these regions, from   2019 to 2025 (forecast).

United States Specialty Injectable Generics market competition by top manufacturers/players, with Specialty Injectable Generics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Fresenius
    Mylan N.V.
    Teva Pharmaceutical
    Hikma Pharmaceuticals
    Novartis AG
    Uman Pharma
    Baxter
    Par Pharmaceutical
    Sagent Pharmaceuticals
    Teligent

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Type I
    Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiovascular
    Central Nervous System
    Infectious Diseases
    Autoimmune Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Specialty Injectable Generics Market  Report 2019
1 Specialty Injectable Generics Overview
    1.1 Product Overview and Scope of Specialty Injectable Generics
    1.2 Classification of Specialty Injectable Generics by Product Category
        1.2.1 United States Specialty Injectable Generics Market Size (Sales Volume) Comparison by Type ( 2014-2024)
        1.2.2 United States Specialty Injectable Generics Market Size (Sales Volume) Market Share by Type (Product Category)  in 2018
        1.2.3 
        1.2.4 
    1.3 United States Specialty Injectable Generics Market by Application/End Users
        1.3.1 United States Specialty Injectable Generics Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Central Nervous System
        1.3.5 Infectious Diseases
        1.3.6 Autoimmune Disorders
    1.4 United States Specialty Injectable Generics Market by Region
        1.4.1 United States Specialty Injectable Generics Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 The West Specialty Injectable Generics Status and Prospect ( 2014-2024)
        1.4.3 Southwest Specialty Injectable Generics Status and Prospect ( 2014-2024)
        1.4.4 The Middle Atlantic Specialty Injectable Generics Status and Prospect ( 2014-2024)
        1.4.5 New England Specialty Injectable Generics Status and Prospect ( 2014-2024)
        1.4.6 The South Specialty Injectable Generics Status and Prospect ( 2014-2024)
        1.4.7 The Midwest Specialty Injectable Generics Status and Prospect ( 2014-2024)
    1.5 United States Market Size (Value and Volume) of Specialty Injectable Generics ( 2014-2024)
        1.5.1 United States Specialty Injectable Generics Sales and Growth Rate ( 2014-2024)
        1.5.2 United States Specialty Injectable Generics Revenue and Growth Rate ( 2014-2024)

2 United States Specialty Injectable Generics Market Competition by Players/Suppliers
    2.1 United States Specialty Injectable Generics Sales and Market Share of Key Players/Suppliers ( 2014-2019)
    2.2 United States Specialty Injectable Generics Revenue and Share by Players/Suppliers ( 2014-2019)
    2.3 United States Specialty Injectable Generics Average Price by Players/Suppliers ( 2014-2019)
    2.4 United States Specialty Injectable Generics Market Competitive Situation and Trends
        2.4.1 United States Specialty Injectable Generics Market Concentration Rate
        2.4.2 United States Specialty Injectable Generics Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Specialty Injectable Generics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Specialty Injectable Generics Sales (Volume) and Revenue (Value) by Region ( 2014-2019)
    3.1 United States Specialty Injectable Generics Sales and Market Share by Region ( 2014-2019)
    3.2 United States Specialty Injectable Generics Revenue and Market Share by Region ( 2014-2019)
    3.3 United States Specialty Injectable Generics Price by Region ( 2014-2019)

4 United States Specialty Injectable Generics Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019)
    4.1 United States Specialty Injectable Generics Sales and Market Share by Type (Product Category) ( 2014-2019)
    4.2 United States Specialty Injectable Generics Revenue and Market Share by Type ( 2014-2019)
    4.3 United States Specialty Injectable Generics Price by Type ( 2014-2019)
    4.4 United States Specialty Injectable Generics Sales Growth Rate by Type ( 2014-2019)

5 United States Specialty Injectable Generics Sales (Volume) by Application ( 2014-2019)
    5.1 United States Specialty Injectable Generics Sales and Market Share by Application ( 2014-2019)
    5.2 United States Specialty Injectable Generics Sales Growth Rate by Application ( 2014-2019)
    5.3 Market Drivers and Opportunities

6  United States Specialty Injectable Generics Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Specialty Injectable Generics Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Fresenius
        6.2.2 Specialty Injectable Generics Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Fresenius Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Mylan N.V.
        6.3.2 Specialty Injectable Generics Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Mylan N.V. Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Teva Pharmaceutical
        6.4.2 Specialty Injectable Generics Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Teva Pharmaceutical Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Hikma Pharmaceuticals
        6.5.2 Specialty Injectable Generics Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Hikma Pharmaceuticals Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Novartis AG
        6.6.2 Specialty Injectable Generics Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis AG Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Uman Pharma
        6.7.2 Specialty Injectable Generics Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Uman Pharma Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Baxter
        6.8.2 Specialty Injectable Generics Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Baxter Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Par Pharmaceutical
        6.9.2 Specialty Injectable Generics Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Par Pharmaceutical Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Sagent Pharmaceuticals
        6.10.2 Specialty Injectable Generics Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Sagent Pharmaceuticals Specialty Injectable Generics Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Teligent

7 Specialty Injectable Generics Manufacturing Cost Analysis
    7.1 Specialty Injectable Generics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Specialty Injectable Generics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Specialty Injectable Generics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Specialty Injectable Generics Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Specialty Injectable Generics Market Size (Value and Volume) Forecast ( 2019-2025)
    11.1 United States Specialty Injectable Generics Sales Volume, Revenue Forecast ( 2019-2025)
    11.2 United States Specialty Injectable Generics Sales Volume Forecast by Type ( 2019-2025)
    11.3 United States Specialty Injectable Generics Sales Volume Forecast by Application ( 2019-2025)
    11.4 United States Specialty Injectable Generics Sales Volume Forecast by Region ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer